“The present situation has uncovered some structural weaknesses inside the EU’s medicines supply chain along with a high dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She proposed that offer chain problems be dealt with in an EU pharmaceutical tactic envisioned to become launched by the end https://www.rilife.co/pharmaceutical-excipients-importers-suppliers-exporters-in-india/